Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouriès, Paola Brescia, Alessandra Silvestri, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 6, pp. 1216-1228
Open Access | Times Cited: 519

Showing 1-25 of 519 citing articles:

The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustı́n Albillos, Andrea De Gottardi, María Rescigno
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 558-577
Open Access | Times Cited: 1433
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 865
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
Cezmi A. Akdiş
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 739-751
Closed Access | Times Cited: 703
Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 375
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 708-724.e11
Open Access | Times Cited: 336
Intestinal Barrier in Human Health and Disease
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12836-12836
Open Access | Times Cited: 336
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 307
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 293
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Zeynep Çelebi Sözener, Betül Özdel Öztürk, Pamir Çerçi, et al.
Allergy (2022) Vol. 77, Iss. 5, pp. 1418-1449
Open Access | Times Cited: 266
The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 255
Multidimensional Impact of Mediterranean Diet on IBD Patients
Fabio Chicco, Salvatore Magrì, Arianna Cingolani, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 1, pp. 1-9
Open Access | Times Cited: 199
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zheng Zhou, Bao Sun, Dongsheng Yu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 196
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 195
Identification of a choroid plexus vascular barrier closing during intestinal inflammation
Sara Carloni, Alice Bertocchi, Sara Mancinelli, et al.
Science (2021) Vol. 374, Iss. 6566, pp. 439-448
Closed Access | Times Cited: 193
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Francesco Violi, Vittoria Cammisotto, Simona Bartimoccia, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 1, pp. 24-37
Open Access | Times Cited: 192
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1881-1898
Open Access | Times Cited: 188
Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
Sonja Lang, Bernd Schnabl
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 233-244
Open Access | Times Cited: 179
Microplastic: A potential threat to human and animal health by interfering with the intestinal barrier function and changing the intestinal microenvironment
Zhuizui Huang, You Weng, Qichen Shen, et al.
The Science of The Total Environment (2021) Vol. 785, pp. 147365-147365
Closed Access | Times Cited: 178
Gut–liver axis: barriers and functional circuits
Oliver Pabst, Mathias W. Hornef, Frank G. Schaap, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 447-461
Closed Access | Times Cited: 170
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 158
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
Haiming Hu, Aizhen Lin, Mingwang Kong, et al.
Journal of Gastroenterology (2019) Vol. 55, Iss. 2, pp. 142-158
Open Access | Times Cited: 151
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 150
Enterically derived high-density lipoprotein restrains liver injury through the portal vein
Yong‐Hyun Han, Emily J. Onufer, Li‐Hao Huang, et al.
Science (2021) Vol. 373, Iss. 6553
Open Access | Times Cited: 146
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
Hongna Mu, Qi Zhou, Ruiyue Yang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 140
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 918-930
Open Access | Times Cited: 131
Page 1 - Next Page

Scroll to top